CMS has already delayed Medicaid managed care once, pushing the start date back to at least March 1, 2016.
If you thought the high-stakes politics in Iowa ended with last week’s caucuses, think again.
The yearlong battle over whether the state’s 560,000 Medicaid beneficiaries will all moved into managed care continues unabated, and the Democrats who have long opposed the move aren’t letting up.
On Monday, two state Senate committees voted on a bill to block Republican Governor Terry Branstad from moving forward with his plan, which he said would save Iowa $51 million in its first 6 months when first proposed. But that was before delays from CMS and lawsuits from spurned contractors. While the bill has symbolic importance, it is not expected to move forward in the Republican-controlled Iowa House.
Branstad’s plan scheduled to proceed January 1, 2016, but CMS found the state was not ready to proceed and delayed the changeover until at least March 1, 2016. In the interim, the Des Moines Register produced documents that show saving estimates were later revised downward to $36.6 million.
Now the stakes are getting even higher. During Monday’s voting, a Republican senator joined Democrats in calling for a delay. Branstad’s predecessor, Democratic former Governor Chet Culver is holding his own town meetings on what opponents are calling Medicaid “privatization.” And the state’s lone Democratic Congressman is making the case to no less than President Obama himself.
US Representative Dave Loebsack released a letter dated Monday, which reads in part, “I have spoken personally to many Iowans who would be impacted by this change, including the parents of children with disabilities. Each these parents are scared that their children will not be able to access the life-sustaining therapies the need once the transition is made. …”
“These parents are not getting the answers they need,” the letter states.
At each step, Branstad has responded to critics by saying that Medicaid spending at current levels was not sustainable, and that a change to managed care was needed to deliver better coordinated care into the future. He especially took issue with Culver’s emergence in the debate, saying that the Democrat spent $440 million in one-time revenues on Medicaid, which Branstad said “dug a big hole” that had to be fixed.
Branstad told the Register, “For (Culver) to now join with the Senate Democrats to try to torpedo a thoughtful, systematic approach to modernize Medicaid to improve the health of Iowans and to better coordinate care, something that has already been done in big states controlled by Democrats like New York and California, I think is outrageous.”
FDA Approves Expanded Indication of Eculizumab for Pediatric Generalized Myasthenia Gravis
March 15th 2025The FDA first approved eculizumab for use in adult patients with generalized myasthenia gravis in 2017, before expanding the indication to include pediatric patients who are 6 years or older and positive for antiacetylcholine receptor antibodies.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Oz Confirmation Hearing Probes Vision for Medicaid but Coalesces Around Well-Being
March 14th 2025Mehmet Oz, MD, the nominee to lead CMS under the Trump administration, testified in a confirmation hearing before the Senate Finance Committee, where he found common ground on improving outcomes through healthier lifestyle choices but encountered repeated questions on potential Medicaid cuts.
Read More